Elasmogen is a therapeutic biologics company that is focused on the development of drugs based on a protein found in a shark’s immune system. It exploits soloMER technology as drugs in small, simple, and stable formats that are amenable to site-specific and systemic delivery. The company uses soloMERs for the sight-saving treatment of inflammatory diseases of the eye and inflammatory conditions of the gut.